CDW vs PPCB · P/E 22, rev $21.00B vs P/E 0.0, $3.9M cap
CDW Corp (CDW) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
CDW Corp (CDW) is a information technology services company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported CDW revenue for 2024-12-31 was $21.00B. Net income was $1.08B. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
PPCB does not have a complete income-statement cache yet.
CDW currently screens at market cap $23.36B and trailing P/E 22.0. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the CDW and PPCB stock pages for the full models.
Not investment advice.